Root Financial Partners
ABUS icon

Root Financial Partners’s Arbutus Biopharma ABUS Stock Holding History

Root Financial Partners’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.35K Buy
+701
New +$3.38K ﹤0.01% 2395
2026
Q2 		– Sell
-281
Closed -$1.26K – 423
2026
Q1 		$1.26K Buy
+281
New +$1.23K ﹤0.01% 2508

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Root Financial Partners's ABUS Position: Q3 2026 in Review

Root Financial Partners opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 701 shares worth $3.35K. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ABUS as recently as Q1 2026.

Root Financial Partners first reported a position in ABUS in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Root Financial Partners held 701 shares of Arbutus Biopharma worth $3.35K as of Q3 2026.
  • Arbutus Biopharma was a new Root Financial Partners position in Q3 2026.
  • Arbutus Biopharma made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2395 holding.
  • Root Financial Partners first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 150 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.